SCM
RMD icon

Segantii Capital Management’s ResMed RMD Stock Holding History

Segantii Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,900
Closed -$693K – 69
2017
Q2 		$693K Hold
8,900
– – 0.17% 49
2017
Q1 		$641K Buy
+8,900
New +$615K 0.11% 74

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Segantii Capital Management's RMD Position: Q3 2017 in Review

Segantii Capital Management sold out of ResMed (RMD) in Q3 2017, closing a stake of 8,900 shares — an estimated $693K sold.

Segantii Capital Management first reported a position in RMD in Q1 2017 and held it in 2 quarters. The position peaked at $693K in Q2 2017. 362 funds tracked by Wall St. Rank hold RMD as of Q3 2017.

  • Segantii Capital Management reported no remaining ResMed position as of Q3 2017 after selling out during the quarter.
  • Segantii Capital Management sold 8,900 ResMed shares in Q3 2017, an estimated $693K.
  • Segantii Capital Management first reported a position in ResMed in Q1 2017 and held it in 2 quarters.
  • Segantii Capital Management's ResMed position peaked at $693K in Q2 2017.
  • 362 funds tracked by Wall St. Rank held ResMed as of Q3 2017.

Based on Segantii Capital Management's 13F filing for Q3 2017, filed 3 Nov 2017.